| Authors: |
Kato S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA., Li B; Ambry Genetics, Aliso Viejo, CA, USA., Adashek JJ; Department of Internal Medicine, University of South Florida, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Cha SW; Ambry Genetics, Aliso Viejo, CA, USA., Bianchi-Frias D; Ambry Genetics, Aliso Viejo, CA, USA., Qian D; Ambry Genetics, Aliso Viejo, CA, USA., Kim L; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA., So TW; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA., Mitchell M; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA., Kamei N; Bio Advanced Technology Division, Corporate R&D Headquarters, Konica Minolta, Inc, Tokyo, Japan., Hoiness R; Ambry Genetics, Aliso Viejo, CA, USA., Hoo J; Ambry Genetics, Aliso Viejo, CA, USA., Gray PN; Ambry Genetics, Aliso Viejo, CA, USA., Iyama T; Bio Advanced Technology Division, Corporate R&D Headquarters, Konica Minolta, Inc, Tokyo, Japan., Kashiwagi M; Bio Advanced Technology Division, Corporate R&D Headquarters, Konica Minolta, Inc, Tokyo, Japan., Lu HM; Ambry Genetics, Aliso Viejo, CA, USA., Kurzrock R; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA. |
